166 related articles for article (PubMed ID: 23362013)
21. Risk scoring system for prediction of contrast-induced nephropathy in patients with pre-existing renal impairment undergoing percutaneous coronary intervention.
Chong E; Shen L; Poh KK; Tan HC
Singapore Med J; 2012 Mar; 53(3):164-9. PubMed ID: 22434288
[TBL] [Abstract][Full Text] [Related]
22. Increased serum asymmetric dimethylarginine level is an independent predictor of contrast-induced nephropathy.
Günebakmaz O; Duran M; Karakaya E; Tanrıkulu E; Akpek M; Ergin A; Kaya MG
Turk Kardiyol Dern Ars; 2013 Oct; 41(7):581-8. PubMed ID: 24164987
[TBL] [Abstract][Full Text] [Related]
23. Safety and efficacy of anisodamine on prevention of contrast induced nephropathy in patients with acute coronary syndrome.
Wang YB; Fu XH; Gu XS; Wang XC; Zhao YJ; Hao GZ; Jiang YF; Fan WZ; Wu WL; Li SQ; Xue L
Chin Med J (Engl); 2012 Mar; 125(6):1063-7. PubMed ID: 22613532
[TBL] [Abstract][Full Text] [Related]
24. Inorganic nitrate benefits contrast-induced nephropathy after coronary angiography for acute coronary syndromes: the NITRATE-CIN trial.
Jones DA; Beirne AM; Kelham M; Wynne L; Andiapen M; Rathod KS; Parakaw T; Adams J; Learoyd A; Khan K; Godec T; Wright P; Antoniou S; Wragg A; Yaqoob M; Mathur A; Ahluwalia A
Eur Heart J; 2024 May; 45(18):1647-1658. PubMed ID: 38513060
[TBL] [Abstract][Full Text] [Related]
25. Short-term high-dose atorvastatin for periprocedural myocardial infarction prevention in patients with renal dysfunction.
Toso A; Leoncini M; Maioli M; Gallopin M; Tedeschi D; Amato M; Bellandi F
J Cardiovasc Med (Hagerstown); 2011 May; 12(5):318-21. PubMed ID: 21045713
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of theophylline in preventing contrast-induced nephropathy after coronary angiographic procedures.
Bilasy ME; Oraby MA; Ismail HM; Maklady FA
J Interv Cardiol; 2012 Aug; 25(4):404-10. PubMed ID: 22612071
[TBL] [Abstract][Full Text] [Related]
27. Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography.
Ling W; Zhaohui N; Ben H; Leyi G; Jianping L; Huili D; Jiaqi Q
Nephron Clin Pract; 2008; 108(3):c176-81. PubMed ID: 18287807
[TBL] [Abstract][Full Text] [Related]
28. Use of estimated glomerular filtration rate for drug dosing in the chronic kidney disease patient.
Hudson JQ; Nyman HA
Curr Opin Nephrol Hypertens; 2011 Sep; 20(5):482-91. PubMed ID: 21709552
[TBL] [Abstract][Full Text] [Related]
29. Prediction of contrast-induced nephropathy in diabetics undergoing elective percutaneous coronary intervention: role of the ratio of contrast medium volume to estimated glomerular filtration rate.
Wang XC; Fu XH; Wang YB; Jia XW; Wu WL; Gu XS; Zhang J; Su JL; Hao GZ; Jiang YF; Fan WZ; Li SQ
Chin Med J (Engl); 2011 Mar; 124(6):892-6. PubMed ID: 21518598
[TBL] [Abstract][Full Text] [Related]
30. Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease.
Toprak O; Cirit M; Esi E; Postaci N; Yesil M; Bayata S
Catheter Cardiovasc Interv; 2006 Feb; 67(2):227-35. PubMed ID: 16400673
[TBL] [Abstract][Full Text] [Related]
31. Prevention of contrast-induced nephropathy with haemofiltration in high-risk patients after percutaneous coronary intervention.
Rey JR; Iglesias D; López De Sá E; Armada E; Moreno R; Salvador O; Monedero Mdel C; Blas SG; Iniesta AM; López-Sendon JL
Acute Card Care; 2011 Sep; 13(3):164-9. PubMed ID: 21877876
[TBL] [Abstract][Full Text] [Related]
32. Clinical survey on contrast-induced nephropathy after coronary angiography.
Wang F; Li J; Huang B; Zhao Q; Yu G; Xuan C; Wei M; Wang N
Ren Fail; 2013 Oct; 35(9):1255-9. PubMed ID: 23944863
[TBL] [Abstract][Full Text] [Related]
33. Does safe dosing of iodinated contrast prevent contrast-induced acute kidney injury?
Brown JR; Robb JF; Block CA; Schoolwerth AC; Kaplan AV; O'Connor GT; Solomon RJ; Malenka DJ
Circ Cardiovasc Interv; 2010 Aug; 3(4):346-50. PubMed ID: 20587788
[TBL] [Abstract][Full Text] [Related]
34. Statins for prevention of contrast-induced nephropathy in patients undergoing non-emergent percutaneous coronary intervention.
Kandula P; Shah R; Singh N; Markwell SJ; Bhensdadia N; Navaneethan SD
Nephrology (Carlton); 2010 Mar; 15(2):165-70. PubMed ID: 20470274
[TBL] [Abstract][Full Text] [Related]
35. The incidence of clinically significant contrast-induced nephropathy following non-emergent coronary angiography.
Weisbord SD; Hartwig KC; Sonel AF; Fine MJ; Palevsky P
Catheter Cardiovasc Interv; 2008 Jun; 71(7):879-85. PubMed ID: 18412255
[TBL] [Abstract][Full Text] [Related]
36. Impact of anemia on contrast-induced nephropathy (CIN) in patients undergoing percutaneous coronary interventions.
Li WH; Li DY; Han F; Xu TD; Zhang YB; Zhu H
Int Urol Nephrol; 2013 Aug; 45(4):1065-70. PubMed ID: 23225080
[TBL] [Abstract][Full Text] [Related]
37. Prediction of Contrast-Induced Nephropathy With Persistent Renal Dysfunction and Adverse Long-term Outcomes in Patients With Acute Myocardial Infarction Using the Mehran Risk Score.
Wi J; Ko YG; Shin DH; Kim JS; Kim BK; Choi D; Ha JW; Hong MK; Jang Y
Clin Cardiol; 2013 Jan; 36(1):46-53. PubMed ID: 23027701
[TBL] [Abstract][Full Text] [Related]
38. Frequency and risk factors of contrast-induced nephropathy after cardiac catheterization in type II diabetic patients: a study among Egyptian patients.
Sany D; Refaat H; Elshahawy Y; Mohab A; Ezzat H
Ren Fail; 2014 Mar; 36(2):191-7. PubMed ID: 24138570
[TBL] [Abstract][Full Text] [Related]
39. The lack of benefit of a combination of an angiotensin receptor blocker and calcium channel blocker on contrast-induced nephropathy in patients with chronic kidney disease.
Oguzhan N; Cilan H; Sipahioglu M; Unal A; Kocyigit I; Kavuncuoglu F; Arikan T; Akpek M; Elcik D; Sahin O; Gulme E; Pala C; Tokgoz B; Utas C; Oguzhan A; Oymak O
Ren Fail; 2013; 35(4):434-9. PubMed ID: 23413781
[TBL] [Abstract][Full Text] [Related]
40. Impact of contrast-induced nephropathy and cardiovascular events by serum cystatin C in renal insufficiency patients undergoing cardiac catheterization.
Ishibashi Y; Yamauchi M; Musha H; Mikami T; Kawasaki K; Miyake F
Angiology; 2010 Nov; 61(8):724-30. PubMed ID: 20947866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
